Mushroom Supplements - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The mushroom supplements market size is expected to grow from USD 5.42 billion in 2025 to USD 5.83 billion in 2026, and is forecast to reach USD 8.83 billion by 2031 at an 8.66% CAGR over 2026-2031. This report is Segmented by Product Type (Reishi, Chaga, and More), Form (Capsules and Tablets, Powder, and More), Function (General Wellness, Cognitive Health, and More), Distribution Channel (Hypermarkets/Supermarkets, Online Retail Stores, and More), and Geography (North America, Europe, Asia-Pacific, South America, and the Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Mushroom Supplements Market Trends and Insights

Rising consumer preference for natural and plant-based wellness supplements

The mushroom supplements market is benefiting from a broader shift in health spending toward products that consumers perceive as closer to food and less reliant on synthetic positioning. In this environment, naturalness has become a screening factor rather than a premium add-on, especially in North America and Europe, where clean-label expectations influence first purchase decisions. In May 2025, Laird Superfood launched six new Organic Mushroom Powders, including Lion's Mane, Reishi, Turkey Tail, Oyster, and specialized Focus & Memory and Calm & Relaxation blends, targeting consumers seeking plant-based wellness solutions. This product expansion highlights how evolving consumer preferences are accelerating innovation and supporting growth in the global mushroom supplements market. This preference also makes buyers more attentive to provenance, extraction methods, and testing language, reducing the effectiveness of weaker claims over time. As the mushroom supplements market matures, brands that clearly communicate sourcing and bioactive content are better positioned to defend premium pricing.

Surging demand for cognitive health and nootropic ingredients

The mushroom supplements market is experiencing one of its strongest demand shifts in cognitive health, with Lion's Mane emerging as the primary growth catalyst. According to a study by Frontiers, a randomized, double-blind, placebo-controlled study published in 2025 found that a single acute dose of standardized Hericium erinaceus (lion's mane mushroom) fruiting body extract improved psychomotor performance in healthy adults aged 18 to 35, giving the category stronger clinical support beyond broad wellness claims. In addition, National Center for Biotechnology Information (NCBI), in 2025, a study reported neuroprotective, antioxidant, and anti-inflammatory effects for Hericium erinaceus and highlighted erinacines as promising neural-stimulating compounds. This evidence aligns with Lion's Mane being the fastest-growing mushroom type. As a result, the mushroom supplements market is shifting from general brain-health positioning toward more specific cognition-led formulations that brands can differentiate more effectively and price at a premium.

Limited global standardization of mushroom extract quality

Mushroom supplements continue to face a major credibility challenge because no single global standard defines how brands should assess or present extract quality to consumers. Industry guidance from the American Herbal Products Association and broader petition activity around fungi labeling indicate rising pressure for clearer language, especially regarding what qualifies as a mushroom ingredient on a supplement label. In Europe, regulators have adopted a more formal approach. The authorization of vitamin D2 mushroom powder under Commission Implementing Regulation 2025/691 shows that authorities are reviewing mushroom-derived ingredients within a more structured safety framework. This development creates uneven compliance pressure, as brands that invest in high-quality extracts and documentation incur costs that lower-priced products do not always bear. As a result, the mushroom supplements market continues to grow amid an inherent tension between category expansion and category trust.

Other drivers and restraints analyzed in the detailed report include:

• Widespread adoption of adaptogenic mushrooms for stress management and holistic wellness
• Increasing clinical research supporting the functional benefits of medicinal mushrooms
• High production costs of premium fruiting body extracts

Segment Analysis

Reishi accounted for 22.81% of mushroom-type revenue in 2025, making it the leading species in the mushroom supplements industry. Its leadership stemmed from its long-standing use in traditional channels and its broad association with immune support and adaptogenic wellness. However, Lion’s Mane is the fastest-growing mushroom type, with a 10.01% CAGR through 2031, highlighting the mushroom supplements market’s shift toward more targeted positioning. The strongest support for this shift comes from peer-reviewed studies linking Hericium erinaceus to cognition, mood, and commercially relevant neuroactive compounds.

Cordyceps is also gaining traction, as its Adenosine Triphosphate (ATP) related positioning aligns more directly with sports nutrition and performance use cases than traditional immune-led messaging. Chaga remains relevant in antioxidant-led products, although the human clinical evidence remains less developed than the evidence supporting Reishi and Lion’s Mane. Turkey Tail stands out because its compound already plays a more clinically grounded role in integrative oncology settings in Japan and China, giving it an unusual medical adjacency within this category. Shiitake maintains a stable position because consumers widely recognize it and require a shorter learning curve, while newer species such as Tremella and Maitake provide the mushroom supplements market with more scope to develop differentiated claims in beauty and metabolic health.

Capsules and tablets accounted for 46.43% of the revenue in 2025, and this format remains the clearest indicator of the mushroom supplements market’s link to routine supplement consumption. Capsules derive their strength from dosing convenience, familiar presentation, and a strong fit with pharmacy-led purchasing habits. Powder is the fastest-growing form, registering a CAGR of 9.78% through 2031, reflecting the mushroom supplements market’s expansion into beverages, smoothies, coffee, and other daily-use formats. This shift in form is significant because powders appeal to consumers who do not want another pill and may first enter the category through food and drink occasions.

Capsules remain relevant, as they continue to support trust, repeatability, and a stronger health-outcome positioning in retail environments. Liquid formats are gaining traction in tinctures and adaptogenic blends, particularly among premium direct-to-consumer brands seeking to offer a faster-acting or more lifestyle-oriented proposition. Other forms, including gummies, are also becoming more visible as brands aim to reduce adherence barriers for new users and broaden household appeal. Overall, the mushroom supplements market is moving toward a more balanced form mix, where capsules maintain credibility, powders drive new consumption occasions, and alternative formats help brands capture consumers at different levels of familiarity and convenience.

Complete Report Scope:

• By Mushroom Type
  • Reishi
  • Lion's Mane
  • Cordyceps
  • Chaga
  • Turkey Tail
  • Shiitake
  • Other Mushroom Types
• By Form
  • Capsules and Tablets
  • Powder
  • Liquid
  • Other Forms
• By Function
  • General Wellness
  • Immunity Support
  • Cognitive Health
  • Energy and Endurance
  • Stress and Anxiety Relief
  • Other Functions
• By Distribution Channel
  • Hypermarkets and Supermarkets
  • Pharmacies and Drug Stores
  • Online Retail Stores
  • Other Distribution Channels
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • United Kingdom
    • Italy
    • France
    • Spain
    • Netherlands
    • Poland
    • Belgium
    • Sweden
    • Rest of Europe
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Indonesia
    • South Korea
    • Thailand
    • Singapore
    • Rest of Asia-Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • Egypt
    • Morocco
    • Turkey
    • Rest of Middle East and Africa

Geography Analysis

North America holds 34.57% of the mushroom supplements market share in 2025. The region benefits from a mature supplement culture, strong brand-building capacity, and a regulatory framework that allows broad product development under dietary supplement rules. This flexibility helps direct-to-consumer brands move faster with new formats, new combinations, and more targeted claims. As a result, demand sophistication and brand proliferation are developing in parallel, making competition active while sustaining innovation.

Asia-Pacific is forecast to grow at a CAGR of 9.96% through 2031. The region combines deep cultural familiarity with medicinal mushrooms, large cultivation capacity, and rapidly modernizing e-commerce systems. India is emerging quickly as wellness spending rises and newer use cases, such as cognition and energy, gain visibility. Japan and South Korea remain mature, quality-oriented markets, where aging populations support stable demand for evidence-based cognitive and immune support. South America and the Middle East and Africa remain earlier-stage regions, but the mushroom supplements market has room to develop in these regions through direct selling, expanding wellness awareness, and broader product availability over time.

Europe stands apart as novel food rules influence which mushroom ingredients or preparations can scale and how quickly they can reach consumers. The authorization of vitamin D2 mushroom powder in Europe in April 2025 is expected to open commercial opportunities in the region. This regulatory environment favors companies that invest early in safety documentation, technical files, and disciplined claim language. Germany, the United Kingdom, France, the Netherlands, and Italy remain the main revenue anchors, as they combine strong health retail infrastructure with higher consumer familiarity with supplements.

List of Companies Covered in this Report:

• Four Sigmatic
• Om Mushroom Superfood
• Real Mushrooms
• Host Defense Mushrooms
• Gaia Herbs
• Fungi Perfecti
• DXN Holdings
• Mushroom Wisdom
• Nammex (North American Medicinal Mushroom Extracts)
• Oriveda
• NutriAvenue
• Bio Answer Holdings, Inc
• MycoNutri
• Sun Potion
• Hokkaido reishi
• Sempera Organics
• Applied Food Sciences, Inc.
• ETHICAL NATURALS, INC.
• Nature's Way Brands, LLC.
• Walgreen Co.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support